LMGAM
EPZM

Liberty Mutual Group Asset Management’s Epizyme, Inc EPZM Stock Holding History

Liberty Mutual Group Asset Management’s Portfolio EPZM Stock Details EPZM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-30,859
Closed -$495K – 12
2020
Q2 		$495K Buy
+30,859
New +$539K 0.07% 9
2019
Q3 		– Sell
-17,623
Closed -$221K – 25
2019
Q2 		$221K Buy
+17,623
New +$227K 0.01% 24

Other funds holding EPZM

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

Liberty Mutual Group Asset Management's EPZM Position: Q3 2020 in Review

Liberty Mutual Group Asset Management sold out of Epizyme, Inc (EPZM) in Q3 2020, closing a stake of 30,859 shares — an estimated $495K sold.

Liberty Mutual Group Asset Management first reported a position in EPZM in Q2 2019 and held it in 2 quarters. The position peaked at $495K in Q2 2020. 151 funds tracked by Wall St. Rank hold EPZM as of Q3 2020.

  • Liberty Mutual Group Asset Management reported no remaining Epizyme, Inc position as of Q3 2020 after selling out during the quarter.
  • Liberty Mutual Group Asset Management sold 30,859 Epizyme, Inc shares in Q3 2020, an estimated $495K.
  • Liberty Mutual Group Asset Management first reported a position in Epizyme, Inc in Q2 2019 and held it in 2 quarters.
  • Liberty Mutual Group Asset Management's Epizyme, Inc position peaked at $495K in Q2 2020.
  • 151 funds tracked by Wall St. Rank held Epizyme, Inc as of Q3 2020.

Based on Liberty Mutual Group Asset Management's 13F filing for Q3 2020, filed 12 Nov 2020.